PISCIS 队列中年龄≥60 岁的艾滋病毒感染者健康相关生活质量低下的预测因素:Vive+ 项目的研究结果

IF 2.8 3区 医学 Q2 INFECTIOUS DISEASES HIV Medicine Pub Date : 2023-12-13 DOI:10.1111/hiv.13590
Andreu Bruguera, L. Egea-Cortés, J. Mesías-Gazmuri, J. Palacio -Vieira, C. G. Forero, C. Miranda, M. Saumoy, E. Fernández, G. Navarro, A. Orti, J. M. Miró, J. Casabona, J. Reyes-Urueña, PISCS Study Group
{"title":"PISCIS 队列中年龄≥60 岁的艾滋病毒感染者健康相关生活质量低下的预测因素:Vive+ 项目的研究结果","authors":"Andreu Bruguera,&nbsp;L. Egea-Cortés,&nbsp;J. Mesías-Gazmuri,&nbsp;J. Palacio -Vieira,&nbsp;C. G. Forero,&nbsp;C. Miranda,&nbsp;M. Saumoy,&nbsp;E. Fernández,&nbsp;G. Navarro,&nbsp;A. Orti,&nbsp;J. M. Miró,&nbsp;J. Casabona,&nbsp;J. Reyes-Urueña,&nbsp;PISCS Study Group","doi":"10.1111/hiv.13590","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Introduction</h3>\n \n <p>Advancements in and accessibility to effective antiretroviral therapy has improved the life expectancy of people living with HIV, increasing the proportion of people living with HIV reaching older age (≥60 years), making this population's health-related quality of life (HRQoL) more relevant. Our aim was to identify the determinants of poor HRQoL in people living with HIV aged ≥60 years and compare them with those of their younger counterparts.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>We used data from the ‘Vive+’ study, a cross-sectional survey conducted between October 2019 and March 2020, nested within the PISCIS cohort of people living with HIV in Catalonia and the Balearic Islands, Spain. We used the 12-item short-form survey (SF-12), divided into a physical component summary (PCS) and a mental component summary (MCS), to evaluate HRQoL. We used the least absolute shrinkage and selection operator for variable selection and used multivariable regression models to identify predictors.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Of the 1060 people living with HIV (78.6% males) who participated in the study, 209 (19.7%) were aged ≥60 years. When comparing older people living with HIV (≥60 years) and their younger counterparts, older people exhibited a worse PCS (median 51.3 [interquartile range {IQR} 46.0–58.1] vs. 46.43 [IQR 42.5–52.7], <i>p</i> &lt; 0.001) but a similar MCS (median 56.0 [IQR 49.34–64.7] vs. 57.0 [IQR 48.9–66.3], <i>p</i> = 0.476). In the multivariable analysis, cognitive function correlated with a PCS (<i>β</i> correlation factor <i>[β]</i> −0.18, <i>p</i> = 0.014), and depressive symptoms and satisfaction with social role correlated with an MCS (<i>β</i> 0.61 and <i>β</i> −0.97, respectively, <i>p</i> &lt; 0.001) in people living with HIV aged ≥60 years.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Depressive symptoms, poor cognitive function, and lower satisfaction with social roles predict poorer HRQoL in older people living with HIV. These factors need to be considered when designing targeted interventions.</p>\n </section>\n </div>","PeriodicalId":13176,"journal":{"name":"HIV Medicine","volume":null,"pages":null},"PeriodicalIF":2.8000,"publicationDate":"2023-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/hiv.13590","citationCount":"0","resultStr":"{\"title\":\"Predictors of poor health-related quality of life among people living with HIV aged ≥60 years in the PISCIS cohort: Findings from the Vive+ project\",\"authors\":\"Andreu Bruguera,&nbsp;L. Egea-Cortés,&nbsp;J. Mesías-Gazmuri,&nbsp;J. Palacio -Vieira,&nbsp;C. G. Forero,&nbsp;C. Miranda,&nbsp;M. Saumoy,&nbsp;E. Fernández,&nbsp;G. Navarro,&nbsp;A. Orti,&nbsp;J. M. Miró,&nbsp;J. Casabona,&nbsp;J. Reyes-Urueña,&nbsp;PISCS Study Group\",\"doi\":\"10.1111/hiv.13590\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Introduction</h3>\\n \\n <p>Advancements in and accessibility to effective antiretroviral therapy has improved the life expectancy of people living with HIV, increasing the proportion of people living with HIV reaching older age (≥60 years), making this population's health-related quality of life (HRQoL) more relevant. Our aim was to identify the determinants of poor HRQoL in people living with HIV aged ≥60 years and compare them with those of their younger counterparts.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>We used data from the ‘Vive+’ study, a cross-sectional survey conducted between October 2019 and March 2020, nested within the PISCIS cohort of people living with HIV in Catalonia and the Balearic Islands, Spain. We used the 12-item short-form survey (SF-12), divided into a physical component summary (PCS) and a mental component summary (MCS), to evaluate HRQoL. We used the least absolute shrinkage and selection operator for variable selection and used multivariable regression models to identify predictors.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>Of the 1060 people living with HIV (78.6% males) who participated in the study, 209 (19.7%) were aged ≥60 years. When comparing older people living with HIV (≥60 years) and their younger counterparts, older people exhibited a worse PCS (median 51.3 [interquartile range {IQR} 46.0–58.1] vs. 46.43 [IQR 42.5–52.7], <i>p</i> &lt; 0.001) but a similar MCS (median 56.0 [IQR 49.34–64.7] vs. 57.0 [IQR 48.9–66.3], <i>p</i> = 0.476). In the multivariable analysis, cognitive function correlated with a PCS (<i>β</i> correlation factor <i>[β]</i> −0.18, <i>p</i> = 0.014), and depressive symptoms and satisfaction with social role correlated with an MCS (<i>β</i> 0.61 and <i>β</i> −0.97, respectively, <i>p</i> &lt; 0.001) in people living with HIV aged ≥60 years.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusion</h3>\\n \\n <p>Depressive symptoms, poor cognitive function, and lower satisfaction with social roles predict poorer HRQoL in older people living with HIV. These factors need to be considered when designing targeted interventions.</p>\\n </section>\\n </div>\",\"PeriodicalId\":13176,\"journal\":{\"name\":\"HIV Medicine\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2023-12-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/hiv.13590\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"HIV Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/hiv.13590\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"HIV Medicine","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/hiv.13590","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

摘要

有效抗逆转录病毒疗法的进步和可及性提高了艾滋病毒感染者的预期寿命,增加了达到老年(≥60岁)的艾滋病毒感染者的比例,使这一人群的健康相关生活质量(HRQoL)更具相关性。我们的目的是确定年龄≥60岁的HIV感染者HRQoL差的决定因素,并将其与年轻的HIV感染者进行比较。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Predictors of poor health-related quality of life among people living with HIV aged ≥60 years in the PISCIS cohort: Findings from the Vive+ project

Introduction

Advancements in and accessibility to effective antiretroviral therapy has improved the life expectancy of people living with HIV, increasing the proportion of people living with HIV reaching older age (≥60 years), making this population's health-related quality of life (HRQoL) more relevant. Our aim was to identify the determinants of poor HRQoL in people living with HIV aged ≥60 years and compare them with those of their younger counterparts.

Methods

We used data from the ‘Vive+’ study, a cross-sectional survey conducted between October 2019 and March 2020, nested within the PISCIS cohort of people living with HIV in Catalonia and the Balearic Islands, Spain. We used the 12-item short-form survey (SF-12), divided into a physical component summary (PCS) and a mental component summary (MCS), to evaluate HRQoL. We used the least absolute shrinkage and selection operator for variable selection and used multivariable regression models to identify predictors.

Results

Of the 1060 people living with HIV (78.6% males) who participated in the study, 209 (19.7%) were aged ≥60 years. When comparing older people living with HIV (≥60 years) and their younger counterparts, older people exhibited a worse PCS (median 51.3 [interquartile range {IQR} 46.0–58.1] vs. 46.43 [IQR 42.5–52.7], p < 0.001) but a similar MCS (median 56.0 [IQR 49.34–64.7] vs. 57.0 [IQR 48.9–66.3], p = 0.476). In the multivariable analysis, cognitive function correlated with a PCS (β correlation factor [β] −0.18, p = 0.014), and depressive symptoms and satisfaction with social role correlated with an MCS (β 0.61 and β −0.97, respectively, p < 0.001) in people living with HIV aged ≥60 years.

Conclusion

Depressive symptoms, poor cognitive function, and lower satisfaction with social roles predict poorer HRQoL in older people living with HIV. These factors need to be considered when designing targeted interventions.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
HIV Medicine
HIV Medicine 医学-传染病学
CiteScore
5.10
自引率
10.00%
发文量
167
审稿时长
6-12 weeks
期刊介绍: HIV Medicine aims to provide an alternative outlet for publication of international research papers in the field of HIV Medicine, embracing clinical, pharmocological, epidemiological, ethical, preclinical and in vitro studies. In addition, the journal will commission reviews and other feature articles. It will focus on evidence-based medicine as the mainstay of successful management of HIV and AIDS. The journal is specifically aimed at researchers and clinicians with responsibility for treating HIV seropositive patients.
期刊最新文献
CROI 2024 BHIVA working group summary Correction to “Severe haematologic toxicity is rare in high risk HIV‐exposed infants receiving combination neonatal prophylaxis” Long COVID among people with HIV: A systematic review and meta‐analysis Issue Information Real-world effectiveness and safety of switching to dolutegravir/lamivudine among people living with HIV-1 aged over 50 years who are virologically suppressed.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1